VitalConnect
Private Company
Total funding raised: $121M
Overview
VitalConnect is a commercial-stage medical technology company focused on remote patient monitoring (RPM) and cardiac monitoring through its flagship wearable biosensor, the VitalPatch. The company's platform streams up to 11 vital signs in real-time, targeting applications in chronic disease management, post-discharge care, hospital-at-home programs, and clinical trials. By providing continuous, telehealth-enabled data, VitalConnect aims to reduce hospital readmissions, improve patient outcomes, and lower the cost of care. The company has seen accelerated growth, particularly driven by the expansion of telehealth during the COVID-19 pandemic.
Technology Platform
Wearable biosensor (VitalPatch) that measures up to 11 vital signs (ECG, HR, RR, temp, posture, etc.) with real-time wireless data streaming to a HIPAA-compliant cloud analytics and telehealth software platform.
Funding History
5Opportunities
Risk Factors
Competitive Landscape
VitalConnect competes in the crowded remote patient monitoring and wearable biosensor market against players like Philips (BioTel), Medtronic, iRhythm, and numerous startups. Its differentiation lies in the multi-parameter sensing (up to 11 vitals) and real-time streaming capabilities of its single patch, as opposed to devices that only store data or measure fewer parameters.